7-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline - CAS 1427391-09-0
Catalog: |
BB009415 |
Product Name: |
7-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline |
CAS: |
1427391-09-0 |
Synonyms: |
6-bromo-4-methyl-2,3-dihydro-1H-quinoxaline; 6-bromo-4-methyl-2,3-dihydro-1H-quinoxaline |
IUPAC Name: | 6-bromo-4-methyl-2,3-dihydro-1H-quinoxaline |
Description: | 7-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline (CAS# 1427391-09-0) is a useful research chemical. |
Molecular Weight: | 227.10 |
Molecular Formula: | C9H11BrN2 |
Canonical SMILES: | CN1CCNC2=C1C=C(C=C2)Br |
InChI: | InChI=1S/C9H11BrN2/c1-12-5-4-11-8-3-2-7(10)6-9(8)12/h2-3,6,11H,4-5H2,1H3 |
InChI Key: | AQBNWIOESLEWRM-UHFFFAOYSA-N |
LogP: | 2.51380 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
TW-202003471-A | SHP2 phosphatase inhibitors and methods of use thereof | 20180321 |
WO-2019183367-A1 | Shp2 phosphatase inhibitors and methods of use thereof | 20180321 |
AU-2019240299-A1 | SHP2 phosphatase inhibitors and methods of use thereof | 20180321 |
BR-112020019385-A2 | SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE OF THE SAME | 20180321 |
CN-112166110-A | SHP2 phosphatase inhibitors and methods of use thereof | 20180321 |
Complexity: | 163 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 226.01056 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 226.01056 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 15.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS